(Q97678477)
Statements
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial (English)
Feng-Cai Zhu
Xu-Hua Guan
Yu-Hua Li
Jian-Ying Huang
Tao Jiang
Li-Hua Hou
Jing-Xin Li
Bei-Fang Yang
Ling Wang
Wen-Juan Wang
Shi-Po Wu
Zhao Wang
Xiao-Hong Wu
Jun-Jie Xu
Zhe Zhang
Si-Yue Jia
Bu-Sen Wang
Yi Hu
Jing-Jing Liu
Jun Zhang
Xiao-Ai Qian
Qiong Li
Hong-Xing Pan
Hu-Dachuan Jiang
Peng Deng
Jin-Bo Gou
Xue-Wen Wang
Xing-Huan Wang